Although earlier studies have showed that FOXM1 contributes to the progression of malignancy in multiple tumor types [57], the mechanism by which FOXM1 simultaneously triggers metastasis and chemoresistance remains poorly understood in CRC. This evidence concerns the gene FOXM1 and neoplasm.